Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shuangqiao ganmao granules
- Development stage
- Unknown
- Lead developer
- Kaken Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuangqiao Ganmao Granules is a Traditional Chinese Medicine (TCM) formulation developed by Huixian Baiquan Traditional Chinese Medicine Research and Development for the treatment of the common cold. The product is based on the traditional 'Shuang-Qiao' herbal pair, which consists of *Lonicera japonica* (Honeysuckle) and *Forsythia suspensa*. These core ingredients are traditionally used in TCM to clear heat, resolve toxicity, and disperse wind-heat pathogens. Pharmacologically, the active phytochemicals within the granules, such as chlorogenic acid and forsythoside A, exhibit anti-inflammatory, antipyretic, and antiviral properties. The formulation is indicated for alleviating symptoms associated with wind-heat type colds, including fever, headache, cough, and sore throat.
- Brand names
- Shuangqiao Ganmao Granules
- Other names
- Shuangqiao Ganmao Keli双翘感冒颗粒
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on shuangqiao ganmao granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shuangqiao ganmao granules.